Symbols / HKPD $0.57 +1.59% Cellyan Biotechnology Co., Ltd

Healthcare • Pharmaceutical Retailers • Hong Kong • NCM
HKPD Chart
About

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Pharmaceutical Retailers Market Cap 13.37M
Enterprise Value 6.05M Income -701.88K Sales 16.36M
Book/sh 0.47 Cash/sh 0.23 Dividend Yield —
Payout 0.00% Employees 27 IPO —
P/E — Forward P/E — PEG —
P/S 0.82 P/B 1.22 P/C —
EV/EBITDA -11.32 EV/Sales 0.37 Quick Ratio 2.51
Current Ratio 2.93 Debt/Eq 44.19 LT Debt/Eq —
EPS (ttm) -0.06 EPS next Y — EPS Growth -83.10%
Revenue Growth -35.70% Earnings — ROA -3.94%
ROE -13.38% ROIC — Gross Margin 8.80%
Oper. Margin 2.96% Profit Margin -4.29% Shs Outstand 23.50M
Shs Float 7.36M Short Float 0.09% Short Ratio 0.05
Short Interest — 52W High 2.76 52W Low 0.37
Beta — Avg Volume 40.65K Volume 4.01K
Target Price — Recom None Prev Close $0.56
Price $0.57 Change 1.59%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.57
Latest analyst target
3. DCF / Fair value
$1.87
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.57
Low
—
High
—
Mean
—
News
RSS: Latest HKPD news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-03-31 2024-03-31 2023-03-31
Total Revenue
20.31
+21.72%
16.69
+32.91%
12.56
Operating Revenue
20.31
+21.72%
16.69
+32.91%
12.56
Cost Of Revenue
17.90
+36.32%
13.13
+33.74%
9.82
Reconciled Cost Of Revenue
17.90
+36.32%
13.13
+33.74%
9.82
Gross Profit
2.42
-32.13%
3.56
+29.93%
2.74
Operating Expense
2.21
+17.45%
1.89
+13.45%
1.66
Selling General And Administration
2.22
+17.28%
1.89
+7.47%
1.76
Other Operating Expenses
-0.00
+63.69%
-0.00
+95.80%
-0.10
Total Expenses
20.11
+33.95%
15.02
+30.81%
11.48
Operating Income
0.20
-88.00%
1.67
+55.35%
1.08
Total Operating Income As Reported
0.13
-91.79%
1.61
+54.08%
1.04
EBITDA
1.21
-52.37%
2.53
+44.11%
1.76
Normalized EBITDA
1.27
-51.27%
2.60
+45.09%
1.79
Reconciled Depreciation
1.07
+15.97%
0.93
+29.53%
0.71
EBIT
0.13
-91.68%
1.61
+54.09%
1.04
Total Unusual Items
-0.06
+6.89%
-0.06
-100.12%
-0.03
Total Unusual Items Excluding Goodwill
-0.06
+6.89%
-0.06
-100.12%
-0.03
Special Income Charges
-0.01
-1162.99%
0.00
0.00
Net Income
-0.03
-102.03%
1.33
+33.21%
1.00
Pretax Income
0.04
-97.63%
1.53
+49.49%
1.02
Net Non Operating Interest Income Expense
-0.10
-16.57%
-0.08
-257.43%
-0.02
Interest Expense Non Operating
0.10
+18.00%
0.08
+256.11%
0.02
Net Interest Income
-0.10
-16.57%
-0.08
-257.43%
-0.02
Interest Expense
0.10
+18.00%
0.08
+256.11%
0.02
Interest Income Non Operating
0.00
+267.30%
0.00
+116.44%
0.00
Interest Income
0.00
+267.30%
0.00
+116.44%
0.00
Other Income Expense
-0.07
-5.76%
-0.06
-95.27%
-0.03
Other Non Operating Income Expenses
-0.01
-325.75%
-0.00
-21.02%
-0.00
Gain On Sale Of Security
-0.05
+19.83%
-0.06
-102.38%
-0.03
Gain On Sale Of Business
0.00
-100.00%
0.01
0.00
Tax Provision
0.06
-67.81%
0.20
+769.37%
0.02
Tax Rate For Calcs
0.00
+28.91%
0.00
+481.82%
0.00
Tax Effect Of Unusual Items
-0.01
-20.03%
-0.01
-1064.33%
-0.00
Net Income Including Noncontrolling Interests
-0.03
-102.03%
1.33
+33.21%
1.00
Net Income From Continuing Operation Net Minority Interest
-0.03
-102.03%
1.33
+33.21%
1.00
Net Income From Continuing And Discontinued Operation
-0.03
-102.03%
1.33
+33.21%
1.00
Net Income Continuous Operations
-0.03
-102.03%
1.33
+33.21%
1.00
Minority Interests
—
0.00
0.00
Normalized Income
0.02
-98.44%
1.38
+34.55%
1.03
Net Income Common Stockholders
-0.03
-102.03%
1.33
+33.21%
1.00
Diluted EPS
-0.00
-102.48%
0.12
+33.21%
0.09
Basic EPS
-0.00
-102.48%
0.12
+33.21%
0.09
Basic Average Shares
10.21
-7.22%
11.00
+0.00%
11.00
Diluted Average Shares
10.21
-7.22%
11.00
+0.00%
11.00
Diluted NI Availto Com Stockholders
-0.03
-102.03%
1.33
+33.21%
1.00
Gain On Sale Of PPE
-0.01
+30.64%
-0.01
0.00
Line Item Trend 2025-03-31 2024-03-31 2023-03-31
Total Assets
9.42
+8.65%
8.67
+154.41%
3.41
Current Assets
8.73
+11.86%
7.80
+183.86%
2.75
Cash Cash Equivalents And Short Term Investments
3.01
+385.10%
0.62
+18.10%
0.52
Cash And Cash Equivalents
0.75
+20.84%
0.62
+18.10%
0.52
Cash Financial
0.75
+20.84%
0.62
+18.10%
0.52
Other Short Term Investments
2.26
0.00
—
Receivables
4.71
+26.74%
3.72
+114.90%
1.73
Accounts Receivable
4.66
+25.88%
3.70
+124.64%
1.65
Gross Accounts Receivable
4.66
+25.88%
3.70
+124.64%
1.65
Allowance For Doubtful Accounts Receivable
0.00
0.00
0.00
Other Receivables
—
—
0.24
Inventory
0.56
-40.00%
0.93
+388.93%
0.19
Raw Materials
0.04
-24.20%
0.05
-18.31%
0.07
Finished Goods
0.52
-40.97%
0.88
+603.92%
0.12
Prepaid Assets
0.45
-64.52%
1.26
+317.23%
0.30
Current Deferred Assets
0.00
-100.00%
1.26
0.00
Restricted Cash
0.00
-94.79%
0.01
0.00
Total Non Current Assets
0.69
-20.26%
0.87
+31.48%
0.66
Net PPE
0.59
-28.78%
0.83
+27.43%
0.65
Gross PPE
0.74
-20.15%
0.92
+30.96%
0.70
Accumulated Depreciation
-0.14
-62.01%
-0.09
-77.92%
-0.05
Properties
0.00
0.00
0.00
Machinery Furniture Equipment
0.02
+0.60%
0.02
-77.71%
0.08
Other Properties
0.65
-23.94%
0.86
+42.59%
0.60
Leases
0.07
+39.04%
0.05
+96.02%
0.02
Goodwill And Other Intangible Assets
0.10
+203.02%
0.03
+689.90%
0.00
Other Intangible Assets
0.10
+203.02%
0.03
+689.90%
0.00
Total Liabilities Net Minority Interest
4.43
+0.32%
4.41
+56.43%
2.82
Current Liabilities
2.92
-8.16%
3.18
+24.56%
2.55
Payables And Accrued Expenses
1.93
-9.72%
2.14
+14.67%
1.86
Payables
1.90
-9.46%
2.10
+16.99%
1.80
Accounts Payable
1.73
+30.58%
1.32
-5.53%
1.40
Other Payable
0.07
+16.23%
0.06
-28.26%
0.08
Current Accrued Expenses
0.03
-25.80%
0.03
-48.66%
0.07
Total Tax Payable
0.11
-51.99%
0.22
+870.73%
0.02
Current Debt And Capital Lease Obligation
0.86
+1.76%
0.85
+102.49%
0.42
Current Debt
0.37
+72.66%
0.22
+245.13%
0.06
Other Current Borrowings
0.37
+105.86%
0.18
+189.47%
0.06
Current Capital Lease Obligation
0.49
-22.29%
0.63
+77.60%
0.36
Current Deferred Liabilities
0.12
-34.84%
0.19
-28.71%
0.27
Current Deferred Revenue
0.12
-34.84%
0.19
-28.71%
0.27
Total Non Current Liabilities Net Minority Interest
1.51
+22.08%
1.24
+355.74%
0.27
Long Term Debt And Capital Lease Obligation
1.51
+22.08%
1.24
+355.74%
0.27
Long Term Debt
1.50
+34.35%
1.12
+857.78%
0.12
Long Term Capital Lease Obligation
0.01
-94.56%
0.12
-23.78%
0.15
Stockholders Equity
4.99
+17.31%
4.25
+626.82%
0.59
Common Stock Equity
4.99
+17.31%
4.25
+626.82%
0.59
Capital Stock
0.01
+10.00%
0.01
+46.13%
0.01
Common Stock
0.01
+10.00%
0.01
+46.13%
0.01
Share Issued
11.00
+0.00%
11.00
+0.00%
11.00
Ordinary Shares Number
11.00
+0.00%
11.00
+0.00%
11.00
Additional Paid In Capital
3.46
+14.80%
3.02
+677.30%
0.39
Retained Earnings
1.50
-1.77%
1.53
+660.27%
0.20
Gains Losses Not Affecting Retained Earnings
0.01
+322.70%
-0.00
-11.88%
-0.00
Other Equity Adjustments
0.01
+322.70%
-0.00
-11.88%
-0.00
Total Equity Gross Minority Interest
4.99
+17.31%
4.25
+626.82%
0.59
Total Capitalization
6.49
+20.86%
5.37
+665.26%
0.70
Working Capital
5.81
+25.61%
4.63
+2231.23%
0.20
Invested Capital
6.87
+22.85%
5.59
+630.99%
0.76
Total Debt
2.37
+13.80%
2.09
+201.97%
0.69
Net Debt
1.13
+57.59%
0.71
—
Capital Lease Obligations
0.50
-33.61%
0.75
+46.98%
0.51
Net Tangible Assets
4.89
+15.91%
4.22
+626.38%
0.58
Tangible Book Value
4.89
+15.91%
4.22
+626.38%
0.58
Duefrom Related Parties Current
0.06
+186.96%
0.02
-76.20%
0.08
Dueto Related Parties Current
0.00
-99.74%
0.50
+72.16%
0.29
Inventories Adjustments Allowances
0.00
0.00
0.00
Line Of Credit
0.00
-100.00%
0.03
0.00
Other Equity Interest
—
-0.30
-4284.04%
-0.01
Line Item Trend 2025-03-31 2024-03-31 2023-03-31
Operating Cash Flow
0.57
+244.35%
-0.39
-122.83%
1.73
Cash Flow From Continuing Operating Activities
0.57
+244.35%
-0.39
-122.83%
1.73
Net Income From Continuing Operations
-0.03
-102.03%
1.33
+33.21%
1.00
Depreciation Amortization Depletion
1.07
+15.97%
0.93
+29.53%
0.71
Depreciation
1.07
+15.97%
0.93
+29.53%
0.71
Depreciation And Amortization
1.07
+15.97%
0.93
+29.53%
0.71
Operating Gains Losses
0.04
+6193.93%
-0.00
—
Gain Loss On Investment Securities
0.04
—
—
Gain Loss On Sale Of PPE
0.00
-100.00%
0.01
0.00
Change In Working Capital
-0.52
+80.36%
-2.65
-18627.77%
0.01
Change In Receivables
-1.02
+51.38%
-2.09
-88.45%
-1.11
Changes In Account Receivables
-0.92
+55.13%
-2.05
-120.28%
-0.93
Change In Inventory
0.38
+150.97%
-0.74
-288.14%
-0.19
Change In Prepaid Assets
—
—
-0.18
Change In Payables And Accrued Expense
0.28
+209.79%
0.09
-90.69%
0.98
Change In Payable
0.28
+209.79%
0.09
-90.69%
0.98
Change In Account Payable
0.40
+477.19%
-0.11
-111.01%
0.96
Change In Other Working Capital
-0.16
-274.64%
0.09
-72.27%
0.34
Investing Cash Flow
-2.45
-5917.66%
-0.04
+69.12%
-0.13
Cash Flow From Continuing Investing Activities
-2.45
-5917.66%
-0.04
+69.12%
-0.13
Net PPE Purchase And Sale
-0.07
-258.41%
-0.02
+82.98%
-0.11
Purchase Of PPE
-0.07
-32.58%
-0.05
+54.00%
-0.11
Sale Of PPE
0.00
-100.00%
0.03
0.00
Capital Expenditure
-0.15
-76.09%
-0.09
+25.22%
-0.12
Net Investment Purchase And Sale
-2.30
0.00
0.00
Purchase Of Investment
-2.30
0.00
0.00
Gain Loss On Sale Of Business
0.00
+100.00%
-0.01
0.00
Net Intangibles Purchase And Sale
-0.09
-141.12%
-0.04
-1052.25%
-0.00
Purchase Of Intangibles
-0.09
-141.12%
-0.04
-1052.25%
-0.00
Net Other Investing Changes
—
0.01
+197.24%
-0.01
Financing Cash Flow
2.00
+271.31%
0.54
+146.49%
-1.16
Cash Flow From Continuing Financing Activities
2.00
+271.31%
0.54
+146.49%
-1.16
Net Issuance Payments Of Debt
-0.93
-348.59%
0.37
+132.28%
-1.16
Issuance Of Debt
1.59
-25.83%
2.14
+1032.32%
0.19
Repayment Of Debt
-2.52
-42.22%
-1.77
-31.57%
-1.34
Long Term Debt Issuance
1.59
-25.83%
2.14
+1032.32%
0.19
Long Term Debt Payments
-2.52
-42.22%
-1.77
-31.57%
-1.34
Net Long Term Debt Issuance
-0.93
-348.59%
0.37
+132.28%
-1.16
Net Common Stock Issuance
4.30
+743.96%
0.51
0.00
Net Other Financing Charges
-1.38
-299.05%
-0.35
—
Changes In Cash
0.11
+7.02%
0.10
-76.74%
0.44
Effect Of Exchange Rate Changes
0.01
+2647.03%
0.00
+41.74%
0.00
Beginning Cash Position
0.63
+19.57%
0.52
+517.34%
0.08
End Cash Position
0.75
+19.43%
0.63
+19.57%
0.52
Free Cash Flow
0.41
+185.88%
-0.48
-129.97%
1.61
Interest Paid Supplemental Data
0.10
+18.00%
0.08
+44.38%
0.06
Income Tax Paid Supplemental Data
0.29
0.00
0.00
Change In Income Tax Payable
-0.11
-158.53%
0.20
+769.37%
0.02
Change In Tax Payable
-0.11
-158.53%
0.20
+769.37%
0.02
Common Stock Issuance
4.30
+743.96%
0.51
0.00
Issuance Of Capital Stock
4.30
+743.96%
0.51
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category